Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Syntel Inc (NASDAQ: SYNT) acted responsibly on behalf of investors’ profitability in the planned sale to Atossa Genetics Inc.

On July 22, 2018, Syntel Inc (NASDAQ: SYNT) and Atossa Genetics Inc announced that they had entered into a merger agreement. Under the terms of the merger agreement, Atossa will acquire all outstanding shares of Syntel for $41.00 per share in an all-cash transaction.    

Based in Troy, Michigan, and founded in 1980 Syntel Inc provides digital transformation, information technology, and knowledge process outsourcing services worldwide.

The investigation focuses on whether NASDAQ: SYNT investors received the highest price and whether the directors of Syntel Inc acted in the best interest of Syntel Inc company and its shareholders.   

If you purchased Syntel Inc (NASDAQ: SYNT) prior to July 22, 2018, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185